Molecular classification of prostate cancer using curated expression signatures - Wikidata - wikimedia - TriplyDB

Molecular classification of prostate cancer using curated expression signatures

Molecular classification of prostate cancer using curated expression signatures

http://www.wikidata.org/entity/Q35641563

about

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment PhysioSpace: relating gene expression experiments from heterogeneous sources using shared physiological processes Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer Inferring pathway dysregulation in cancers from multiple types of omic data.Surprisal analysis of transcripts expression levels in the presence of noise: a reliable determination of the onset of a tumor phenotype.NF-κB gene signature predicts prostate cancer progression.Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.Copy number alteration burden predicts prostate cancer relapse Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.Prevention and early detection of prostate cancer.p53: the barrier to cancer stem cell formation.p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer QCanvas: An Advanced Tool for Data Clustering and Visualization of Genomics Data MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays.Hexokinase 2-mediated Warburg effect is required for PTEN- and p53-deficiency-driven prostate cancer growth.A new texture and shape based technique for improving meningioma classification.Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer.Profiling prostate cancer.Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error.Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan.Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.Study design requirements for RNA sequencing-based breast cancer diagnostics A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate Cancer Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study Distance in cancer gene expression from stem cells predicts patient survival.A basal stem cell signature identifies aggressive prostate cancer phenotypes.Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models Endosomal gene expression: a new indicator for prostate cancer patient prognosis?Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.Pathway-based personalized analysis of cancer Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer.Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer.Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity A colorectal cancer classification system that associates cellular phenotype and responses to therapy miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients.Embryonic stem cells shed new light on the developmental roles of p53.

P2860

Q24633279-7D27ED5F-34E3-4B67-9054-3A5C0816027E Q28391523-ED054A78-140A-46E7-AD65-3326B3F4B0AA Q28534493-A06645C2-6D19-4C45-BE4B-A07112F1E7D3 Q30938412-7088384C-560A-45FB-87EA-EB4E1AC9D127 Q30980125-74290BC2-62DE-4908-8637-37BB8ACBD447 Q31116154-9693CDBC-9623-4F32-A4FA-B27AFB9C077A Q33624908-7244FF0D-9A04-4C9F-AFA7-06350D282C52 Q33677773-0B231C92-752C-43EA-AC42-C62B28EBDA96 Q33789808-FCD1AC30-F980-45D8-8BC8-B4B2F8026EF9 Q34002312-B99EB0E6-F869-444F-86EA-7603D4767857 Q34129290-64E54C34-C8C9-4832-A095-C6DAE8873054 Q34371057-F5E63F69-59D2-4B24-AE0B-D8ADFA8E60F6 Q34406072-D4114062-C8CC-46FF-B191-640430E179FD Q34457367-647B7E95-D558-46B5-BFDD-2AA56BCB9F03 Q34560696-EC8DB5A8-ED2F-419B-97B7-61D7A8683916 Q34574636-0355A750-3F75-496F-B10E-4119E6A5B754 Q35180333-C8B977F1-2068-4457-A069-150336297AE8 Q35212879-AC31EB6D-6284-4884-A65E-80D31AC508E2 Q35223291-A9B7B63A-CC58-40F5-A652-B2409BE1D0F5 Q35641430-39C1CDAC-2F9B-455A-BDF1-AE477E121DA8 Q35678391-D0457BA7-736B-4CCC-B97B-0F6EB3E81E1B Q35815161-FBA35241-2BE5-431C-AC02-0A7853F4475E Q35903128-8527AB14-0C83-46AB-86AE-5FBF456A8617 Q35910164-6234664C-1625-4E59-BDB1-5A029643149E Q35996026-50F34734-7288-4D48-AFFC-B93EC0C89134 Q36106271-6B2B032A-360D-4194-A1DC-58352E110BF2 Q36319754-693552AC-E646-4993-AF5C-13954A645BBF Q36332070-360B0D6E-0CCA-46ED-96DC-523AB8FFC0CD Q36368188-CAFA238A-5280-4390-B3CD-A17ADA23CDD8 Q36435777-E2AA4A3A-60C0-4988-946F-231F104B5724 Q36545920-872B5EAA-4063-42ED-A597-3E15224CD7A3 Q36580194-36D35E91-B291-4A70-8122-2A25E521091A Q36782228-779D04D0-3510-4EDE-9522-1A0C4E10C5C2 Q36959119-69965491-E729-4D78-B31D-4DEE36AD814C Q36979944-B31F3EB4-AEC2-4BE0-BB1F-18D5870127A6 Q37008469-2DB68366-8281-45D3-B320-0022E7512311 Q37094872-BCE1B2D9-0FC8-4BA4-9103-B1FE20D89B38 Q37175913-B1A4EE60-4A0E-4F95-B9C9-979DF6B9CAEB Q37340886-55A8A6EA-E618-4118-B05F-25A40F3FBF1E Q37367149-EDBF09BB-921F-42FC-A20D-81C430DC0D9A

P2860

Molecular classification of prostate cancer using curated expression signatures

http://www.wikidata.org/entity/Q35641563

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Molecular classification of prostate cancer using curated expression signatures

@ast

Molecular classification of prostate cancer using curated expression signatures

@en

type

label

Molecular classification of prostate cancer using curated expression signatures

@ast

Molecular classification of prostate cancer using curated expression signatures

@en

prefLabel

Molecular classification of prostate cancer using curated expression signatures

@ast

Molecular classification of prostate cancer using curated expression signatures

@en

P1433

Q35641563-00848C8A-885D-4FB0-AF78-ACAC478DAAC0

P1476

Q35641563-13A109B8-DFAA-42A8-9D7E-4F2E18E69DEC

P2093

Q35641563-73EB5D88-E447-4F1E-8C58-2D9443C7DCD5

Q35641563-D51319D6-0BEA-45FE-B511-77030F406C61

Q35641563-E4A9D9AD-286B-4A9F-9997-F31A68DEC018

Q35641563-F35DC4E7-20E8-4BFB-AF02-AE095D07CFFD

P2860

Q35641563-0058E301-3449-420D-8356-8DC4879C1181

Q35641563-01239B59-86C3-47AC-82DA-704448A26A5F

Q35641563-0ECC51DD-04BF-410E-9397-359267FF945B

Q35641563-1B6352F3-4FAC-4128-AA29-46B8CACEE704

Q35641563-1F1B43E4-41C5-4D6E-BE9C-BD860792C0CC

Q35641563-2EA3E01F-F2DC-4377-BF36-D217B9127D57

Q35641563-2EEFC4F0-FCE1-45A7-B657-1533C92FAC3E

Q35641563-376B2D77-813E-4EB5-B587-FC068442DF2E

Q35641563-3818E77C-7942-41BA-97C6-3F3AA041B336

Q35641563-401B8881-C3B9-4A4F-B4D2-E8F17DFE06A9

P304

Q35641563-C53E8A4D-2553-4F8D-9AA8-68E78CBBD370

P31

Q35641563-E94932FE-2853-42D3-9434-8592DB55BB55

P356

Q35641563-53062EEA-80D5-4FA9-A86F-53C499AB5C35

P407

Q35641563-A83CFA60-2092-4F93-81C8-85651153325C

P433

Q35641563-42816B02-3C60-413D-BBC9-17D32D11BA95

P478

Q35641563-1A7E8F4F-BC90-489B-B301-DC12007A8315

P577

Q35641563-49E8AB7B-51C3-4E3B-87B5-1969E5962508

P5875

Q35641563-79CB4E89-3746-4376-9A3C-6C0650E4D7E4

P698

Q35641563-F9E63E5B-64C2-4399-BA1E-C06F4E61EC22

P932

Q35641563-E591CB9C-ADB0-42E7-9B3C-3068D666AA47

P356

PNAS.1117029108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Molecular classification of prostate cancer using curated expression signatures

@en

P2093

Alexei Vazquez

http://www.w3.org/2001/XMLSchema#string

Arnold J Levine

http://www.w3.org/2001/XMLSchema#string

Elke K Markert

http://www.w3.org/2001/XMLSchema#string

Hideaki Mizuno

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Direct cell reprogramming is a stochastic process amenable to acceleration

MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Molecular portraits of human breast tumours

Role of the TMPRSS2-ERG gene fusion in prostate cancer

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity

The Ink4/Arf locus is a barrier for iPS cell reprogramming

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

P304

21276-21281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1117029108

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51833035

http://www.w3.org/2001/XMLSchema#string

P698

22123976

http://www.w3.org/2001/XMLSchema#string

P932

3248553

http://www.w3.org/2001/XMLSchema#string